Clinical value of an adenosine triphosphate-based chemotherapy response assay in resectable stage III colorectal cancer.

Conclusion: ATP-CRA tailored-chemotherapy has the potential to provide a survival benefit in resectable advanced CRC. PMID: 31384612 [PubMed]
Source: Annals of Surgical Treatment and Research - Category: Surgery Tags: Ann Surg Treat Res Source Type: research